BeOne Medicines Ltd.

Direct answer

BeOne Medicines Ltd. is publicly traded on NASDAQ under the ticker ONC.

BeOne Medicines Ltd. (ONC), initially founded in 2010 as BeiGene, stands as a prominent global oncology enterprise committed to identifying, advancing, and bringing to market cutting-edge cancer treatments. The company underwent a significant transformation, rebranding as BeOne in late 2024 and subsequently relocating its headquarters from Cambridge, Massachusetts, to Basel, Switzerland, in 2025. With a vast...

Can you invest in BeOne Medicines Ltd.?

Yes. BeOne Medicines Ltd. is publicly traded on NASDAQ under the ticker ONC.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for BeOne Medicines Ltd.

Detailed equity research is provided by MarketSnap.